NDUFAF7

Across TCGA pan-cancer cohorts, NDUFAF7 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NDUFAF7 data layer compared with 26 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher NDUFAF7 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated NDUFAF7 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

PDAC, HNSC, and LUAD are the cancer types where NDUFAF7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Quartile	All	0.294	0.719	<.001	23	view →
HNSC	DFS	Median	IV	0.328	0.889	.014	3	view →
LUAD	DFS	Quartile	All	1.000	0.604	.015	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

NDUFAF7–PDAC (OS)

Open the PDAC breakdown →